The cytoplasmic Purkinje onconeural antigen cdr2 down-regulates c-Myc function: implications for neuronal and tumor cell survival.

Paraneoplastic cerebellar degeneration (PCD) is a disorder in which breast or ovarian tumors express an onconeural antigen termed cdr2, which normally is expressed in cerebellar Purkinje neurons. This leads to an immune response to cdr2 that is associated with tumor immunity and autoimmune cerebellar degeneration. We have found that cdr2, a cytoplasmic protein harboring a helix-leucine zipper (HLZ) motif, interacts specifically with the HLZ motif of c-Myc. Both proteins colocalize in the cytoplasm of adult cerebellar Purkinje neurons, and coimmunoprecipitate from tumor cell lines and cerebellar extracts. cdr2 down-regulates c-Myc-dependent transcription in cotransfection assays, and redistributes Myc protein in the cytoplasm. Disease antisera from six of six PCD patients specifically blocked the interaction between cdr2 and c-Myc in vitro. These data indicate that cdr2 normally sequesters c-Myc in the neuronal cytoplasm, thereby down-regulating c-Myc activity, and suggest a mechanism whereby inhibition of cdr2 function by autoantibodies in PCD may contribute to Purkinje neuronal death.

[1]  Loise M. Francisco,et al.  Tumor-specific killer cells in paraneoplastic cerebellar degeneration , 1998, Nature Medicine.

[2]  C. Prives.  Signaling to p53 Breaking the MDM2–p53 Circuit , 1998, Cell.

[3]  C. Shatz,et al.  Regulation of Class I MHC Gene Expression in the Developing and Mature CNS by Neural Activity , 1998, Neuron.

[4]  L. Naumovski,et al.  Interferon-induced upregulation and cytoplasmic localization of Myc-interacting protein Nmi. , 1998, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

[5]  G. Evan,et al.  A matter of life and cell death. , 1998, Science.

[6]  M. Cole,et al.  The Novel ATM-Related Protein TRRAP Is an Essential Cofactor for the c-Myc and E2F Oncoproteins , 1998, Cell.

[7]  J L Cleveland,et al.  Myc signaling via the ARF tumor suppressor regulates p53-dependent apoptosis and immortalization. , 1998, Genes & development.

[8]  Y. Ono,et al.  PKN interacts with a paraneoplastic cerebellar degeneration-associated antigen, which is a potential transcription factor. , 1998, Experimental cell research.

[9]  G. Burg,et al.  c-myc Is Not Useful as Prognostic Immunohistochemical Marker in Cutaneous Melanoma , 1998, Dermatology.

[10]  G. Evan,et al.  Specific TrkA survival signals interfere with different apoptotic pathways , 1998, Oncogene.

[11]  D. Green.  A Myc-Induced Apoptosis Pathway Surfaces , 1997, Science.

[12]  G. Carmichael,et al.  An alternative pathway for gene regulation by Myc , 1997, The EMBO journal.

[13]  David M. Rothwarf,et al.  A cytokine-responsive IκB kinase that activates the transcription factor NF-κB , 1997, Nature.

[14]  M. Hauchecorne,et al.  Expression and subcellular localization of the Myc superfamily proteins: c-Myc, Max, Mad1 and Mxi1 in the epiphyseal plate cartilage chondrocytes of growing rats. , 1997, Cellular and molecular biology.

[15]  Bas van Steensel,et al.  Control of telomere length by the human telomeric protein TRF1 , 1997, Nature.

[16]  J. Darnell,et al.  A Post-Transcriptional Regulatory Mechanism Restricts Expression of the Paraneoplastic Cerebellar Degeneration Antigen cdr2 to Immune Privileged Tissues , 1997, The Journal of Neuroscience.

[17]  Robert Wechsler-Reya,et al.  BIN1 is a novel MYC–interacting protein with features of a tumour suppressor , 1996, Nature Genetics.

[18]  D. Beach,et al.  Cdc25 cell-cycle phosphatase as a target of c-myc , 1996, Nature.

[19]  A. Zervos,et al.  Isolation and characterization of Nmi, a novel partner of Myc proteins. , 1996, Oncogene.

[20]  J. Bluestone,et al.  CD28/B7 system of T cell costimulation. , 1996, Annual review of immunology.

[21]  N. Copeland,et al.  Mad3 and Mad4: novel Max‐interacting transcriptional repressors that suppress c‐myc dependent transformation and are expressed during neural and epidermal differentiation. , 1995, The EMBO journal.

[22]  M. Schmitz,et al.  Multi-Step Activation of NF-κB/Rel Transcription Factors , 1995 .

[23]  V. Kosma,et al.  Expression of c-myc proteins in breast cancer as related to established prognostic factors and survival. , 1995, Anticancer research.

[24]  H. Orr,et al.  In Vivo Viability of Postmitotic Purkinje Neurons Requires pRb Family Member Function , 1995, Molecular and Cellular Neuroscience.

[25]  T. Curran,et al.  Immediate-early genes: ten years on , 1995, Trends in Neurosciences.

[26]  P. Lipponen.  Expression of c‐myc protein is related to cell proliferation and expression of growth factor receptors in transitional cell bladder cancer , 1995, The Journal of pathology.

[27]  C. Papadimitriou,et al.  Immunohistochemical detection of the c-myc oncogene product in normal, hyperplastic and carcinomatous endometrium. , 1994, Oncology.

[28]  H. Awano,et al.  Ultrastructural localization of anti-Purkinje cell antibody-binding sites in paraneoplastic cerebellar degeneration. , 1994, Archives of neurology.

[29]  S. Goff,et al.  Inhibition of transcriptional regulator Yin-Yang-1 by association with c-Myc. , 1993, Science.

[30]  A. Miyazawa,et al.  Immunohistochemical Analysis of Signal Transduction System in Developing Rat Purkinje Cell by Using Antibodies for Signaling Molecules , 1993, Annals of the New York Academy of Sciences.

[31]  A. Miyazawa,et al.  Regulation of c-MYC protein expression in the developing rat cerebellum by phosphoinositide turnover. , 1993, Biochemical and biophysical research communications.

[32]  S. Elledge,et al.  The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases , 1993, Cell.

[33]  M. Kastan,et al.  Altered cytoplasmic/nuclear distribution of the c-myc protein in differentiating ML-1 human myeloid leukemia cells. , 1993, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[34]  N. Heintz.  Cell death and the cell cycle: a relationship between transformation and neurodegeneration? , 1993, Trends in biochemical sciences.

[35]  K. Jaeckle,et al.  Analysis of autoantibody binding to 52‐kd paraneoplastic cerebellar degeneration–associated antigen expressed in recombinant proteins , 1993, Annals of neurology.

[36]  Hisato Kondoh,et al.  Transition of localization of the N-Myc protein from nucleus to cytoplasm in differentiating neurons , 1993, Neuron.

[37]  R. Eisenman,et al.  Mad: A heterodimeric partner for Max that antagonizes Myc transcriptional activity , 1993, Cell.

[38]  W. Hickey,et al.  Characterization of microglia and macrophages in the central nervous system of rats: Definition of the differential expression of molecules using standard and novel monoclonal antibodies in normal CNS and in four models of parenchymal reaction , 1993, Glia.

[39]  H. Orr,et al.  Disrupted cerebellar cortical development and progressive degeneration of Purkinje cells in SV40 T antigen transgenic mice , 1992, Neuron.

[40]  R. Eisenman,et al.  Myc and Max proteins possess distinct transcriptional activities , 1992, Nature.

[41]  M. Rosenblum,et al.  Paraneoplastic cerebellar degeneration. , 1992, Neurology.

[42]  M. Méchali,et al.  Comparative analysis of the intracellular localization of c-Myc, c-Fos, and replicative proteins during cell cycle progression , 1992, Molecular and cellular biology.

[43]  H. Sasano,et al.  Immunolocalization of c-myc oncoprotein in mucinous and serous adenocarcinomas of the ovary. , 1992, Human pathology.

[44]  R. M. Sharrard,et al.  Cellular localisation of C‐myc product in human colorectal epithelial neoplasia , 1992, The Journal of pathology.

[45]  I. Illa,et al.  Effect of intraventricular injection of an anti-Purkinje cell antibody (anti-Yo) in a guinea pig model , 1991, Journal of the Neurological Sciences.

[46]  J. Posner,et al.  Cloning of a leucine-zipper protein recognized by the sera of patients with antibody-associated paraneoplastic cerebellar degeneration. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[47]  D. Mitchell,et al.  Isolation of a complementary DNA clone encoding an autoantigen recognized by an anti‐neuronal cell antibody from a patient with paraneoplastic cerebellar degeneration , 1990, Annals of neurology.

[48]  J. Posner,et al.  Autoantibody synthesis in the central nervous system of patients with paraneoplastic syndromes , 1990, Neurology.

[49]  R. Fabian,et al.  Intraneuronal IgG in the central nervous system , 1987, Neurology.

[50]  E. Baulieu,et al.  Antiglucocorticosteroid effects suggest why steroid hormone is required for receptors to bind DNA in vivo but not in vitro , 1987, Nature.

[51]  T. Curran,et al.  Mapping patterns of c-fos expression in the central nervous system after seizure. , 1987, Science.

[52]  Yao-Tseng Chen,et al.  Cloning of a brain protein identified by autoantibodies from a patient with paraneoplastic cerebellar degeneration. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[53]  D. Goldowitz,et al.  Proto‐oncogene c‐myc is expressed in cerebellar neurons at different developmental stages. , 1986, The EMBO journal.

[54]  S. Iversen,et al.  Selective extraction of small and large molecules from the cerebrospinal fluid by Purkinje neurons. , 1985, Science.

[55]  R. Eisenman,et al.  Mnt, a novel Max-interacting protein is coexpressed with Myc in proliferating cells and mediates repression at Myc binding sites. , 1997, Genes & development.

[56]  P. Hogan,et al.  Transcription factors of the NFAT family: regulation and function. , 1997, Annual review of immunology.

[57]  Frank Lieberman,et al.  Inflammatory infiltrates and complete absence of Purkinje cells in anti-Yo-associated paraneoplastic cerebellar degeneration , 1996, Acta Neuropathologica.

[58]  N. Copeland,et al.  Mad3 and Mad4: novel Max-interacting transcriptional repressors that suppress c-myc dependent transformation and are expressed during neural and epidermal differentiation. , 1996, The EMBO journal.

[59]  G. Mower,et al.  Changes in immediate early gene expression during postnatal development of cat cortex and cerebellum. , 1992, Brain research. Molecular brain research.

[60]  R. Eisenman,et al.  Myc and Max associate in vivo. , 1992, Genes & development.

[61]  D. Mitchell,et al.  Isolation of a complementary DNA clone encoding an autoantigen recognized by an anti-neuronal cell antibody from a patient with paraneoplastic cerebellar degeneration. , 1991, Annals of neurology.

[62]  M. Ito.  A new physiological concept on cerebellum. , 1990, Revue neurologique.